| Item Type | Name |
|
Academic Article
|
Metastasectomy after targeted therapy in patients with advanced renal cell carcinoma.
|
|
Academic Article
|
p53 predictive value for pT1-2 N0 disease at radical cystectomy.
|
|
Academic Article
|
Survivin as a prognostic marker for urothelial carcinoma of the bladder: a multicenter external validation study.
|
|
Concept
|
Carcinoma in Situ
|
|
Concept
|
Carcinoma, Non-Small-Cell Lung
|
|
Concept
|
Adrenocortical Carcinoma
|
|
Concept
|
Carcinoma, Papillary
|
|
Concept
|
Carcinoma
|
|
Concept
|
Carcinoma, Renal Cell
|
|
Concept
|
Carcinoma, Squamous Cell
|
|
Concept
|
Carcinoma, Transitional Cell
|
|
Concept
|
Carcinoma, Medullary
|
|
Academic Article
|
Hypoxia-induced SUMOylation of E3 ligase HAF determines specific activation of HIF2 in clear-cell renal cell carcinoma.
|
|
Academic Article
|
Role of urinary cathepsin B and L in the detection of bladder urothelial cell carcinoma.
|
|
Academic Article
|
Development and characterization of clinically relevant tumor models from patients with renal cell carcinoma.
|
|
Academic Article
|
Re: Illness uncertainty and quality of life of patients with small renal tumors undergoing watchful waiting: a 2-year prospective study.
|
|
Academic Article
|
Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy.
|
|
Academic Article
|
Urine cytology and urine-based markers for bladder urothelial carcinoma detection and monitoring: developments and future prospects.
|
|
Academic Article
|
Radio frequency ablation of renal tumors in patients with metastatic renal cell carcinoma.
|
|
Academic Article
|
The dark side of targeted therapy.
|
|
Academic Article
|
Laparoscopic adrenalectomy for metachronous metastases after ipsilateral nephrectomy for renal-cell carcinoma.
|
|
Academic Article
|
Higher perioperative morbidity and in-hospital mortality in patients with end-stage renal disease undergoing nephrectomy for non-metastatic kidney cancer: a population-based analysis.
|
|
Academic Article
|
The effects of temporary ischemia in partial nephrectomy on renal functional outcomes: how can effects best be estimated, and can they be mitigated?
|
|
Academic Article
|
Biomarkers of renal cell carcinoma.
|
|
Academic Article
|
Role of metastasectomy for metastatic renal cell carcinoma in the era of targeted therapy.
|
|
Academic Article
|
Urinary levels of tumor-associated trypsin inhibitor (TATI) in the detection of transitional cell carcinoma of the urinary bladder.
|
|
Academic Article
|
The application of epigenetic modifiers on the treatment of prostate and bladder cancer.
|
|
Academic Article
|
The use of histone deacetylase inhibitor FK228 and DNA hypomethylation agent 5-azacytidine in human bladder cancer therapy.
|
|
Academic Article
|
Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder.
|
|
Academic Article
|
Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.
|
|
Academic Article
|
Genomics: a preview of genomic medicine.
|
|
Academic Article
|
The impact of targeted molecular therapies on the level of renal cell carcinoma vena caval tumor thrombus.
|
|
Academic Article
|
The role of surgery in advanced renal cell carcinoma: cytoreductive nephrectomy and metastasectomy.
|
|
Academic Article
|
Management of small renal masses: watch, cut, freeze, or fry?
|
|
Academic Article
|
Percutaneous cryoablation of solitary sporadic renal cell carcinomas.
|
|
Academic Article
|
Metabolism of kidney cancer: from the lab to clinical practice.
|
|
Academic Article
|
Upregulation of TRAG3 gene in urothelial carcinoma of the bladder.
|
|
Academic Article
|
Editorial comment: Improved cancer specific-survival in patients with carcinoma invading bladder muscle expressing cyclo-oxygenase-2.
|
|
Academic Article
|
Illness uncertainty and quality of life of patients with small renal tumors undergoing watchful waiting: a 2-year prospective study.
|
|
Academic Article
|
Radiofrequency ablation of renal tumours with clinical, radiographical and pathological results.
|
|
Academic Article
|
Robotic partial nephrectomy shortens warm ischemia time, reducing suturing time kinetics even for an experienced laparoscopic surgeon: a comparative analysis.
|
|
Academic Article
|
Carcinoma in situ of the upper urinary tract treated with radical nephroureterectomy--results from a multicenter study.
|
|
Academic Article
|
Words of wisdom. Re: Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. Hudes G, Carducci M, Tomczak P, Dutcher J, Figlin R, Kapoor A, Staroslawska E, Sosman J, McDermott D, Bodrogi I, Kovacevic Z, Lesovoy V, Schmidt-Wolf IG, Barbarash O, Gokmen E, O'Toole T, Lustgarten S, Moore L, Motzer RJ; Global ARCC Trial. N Engl J Med 2007;356:2271-81.
|
|
Academic Article
|
Positive vascular wall margins have minimal impact on cancer outcomes in patients with non-metastatic renal cell carcinoma (RCC) with tumour thrombus.
|
|
Academic Article
|
Insulin-like growth factor messenger RNA-binding protein 3 expression helps prognostication in patients with upper tract urothelial carcinoma.
|
|
Academic Article
|
Partial nephrectomy in the setting of metastatic renal cell carcinoma.
|
|
Academic Article
|
Phase 2 trial of neoadjuvant axitinib in patients with locally advanced nonmetastatic clear cell renal cell carcinoma.
|
|
Academic Article
|
Salvage surgery after energy ablation for renal masses.
|
|
Academic Article
|
Population-based analysis of factors associated with survival in patients undergoing cytoreductive nephrectomy in the targeted therapy era.
|
|
Academic Article
|
Lymphatic drainage in renal cell carcinoma: back to the basics.
|
|
Academic Article
|
Treating the two extremes in renal cell carcinoma: management of small renal masses and cytoreductive nephrectomy in metastatic disease.
|
|
Academic Article
|
For the RECORD, we should SWITCH our treatment AXIS before the SUNRISES and TARGET the BEST treatments before INTORSECTing with a GOLD METEOR: a tale of sequences and combinations.
|
|
Academic Article
|
RNA-seq reveals aurora kinase-driven mTOR pathway activation in patients with sarcomatoid metastatic renal cell carcinoma.
|
|
Academic Article
|
Preoperative predictors of pathological lymph node metastasis in patients with renal cell carcinoma undergoing retroperitoneal lymph node dissection.
|
|
Academic Article
|
Mucinous tubular and spindle cell carcinoma (MTSCC) of the kidney: a detailed study of radiological, pathological and clinical outcomes.
|
|
Academic Article
|
Evaluation of the prognostic significance of altered mammalian target of rapamycin pathway biomarkers in upper tract urothelial carcinoma.
|
|
Academic Article
|
Multi-institutional validation of the predictive value of Ki-67 in patients with high grade urothelial carcinoma of the upper urinary tract.
|
|
Academic Article
|
Reporting geographic and temporal trends in renal cell carcinoma: why is this important?
|
|
Academic Article
|
Genomic investigation of etiologic heterogeneity: methodologic challenges.
|
|
Academic Article
|
Clinically nonmetastatic renal cell carcinoma with sarcomatoid dedifferentiation: Natural history and outcomes after surgical resection with curative intent.
|
|
Academic Article
|
Surgical Management of Local Retroperitoneal Recurrence of Renal Cell Carcinoma after Radical Nephrectomy.
|
|
Academic Article
|
Prospective evaluation of plasma levels of ANGPT2, TuM2PK, and VEGF in patients with renal cell carcinoma.
|
|
Academic Article
|
Percentage of sarcomatoid component as a prognostic indicator for survival in renal cell carcinoma with sarcomatoid dedifferentiation.
|
|
Academic Article
|
Resistance to Antiangiogenic Therapy Is Associated with an Immunosuppressive Tumor Microenvironment in Metastatic Renal Cell Carcinoma.
|
|
Academic Article
|
Intratumoral morphologic and molecular heterogeneity of rhabdoid renal cell carcinoma: challenges for personalized therapy.
|
|
Academic Article
|
Role of metastasectomy in metastatic renal cell carcinoma.
|
|
Academic Article
|
Survivin is not an independent prognostic factor for patients with upper tract urothelial carcinoma: a multi-institutional study.
|
|
Academic Article
|
Role of targeted therapy in combination with surgery in renal cell carcinoma.
|
|
Academic Article
|
Prediction of Pulmonary Metastasis in Renal Cell Carcinoma Patients with Indeterminate Pulmonary Nodules.
|
|
Academic Article
|
Surgical considerations for patients with metastatic renal cell carcinoma.
|
|
Academic Article
|
Gene-environment interaction of genome-wide association study-identified susceptibility loci and meat-cooking mutagens in the etiology of renal cell carcinoma.
|
|
Academic Article
|
Metastatic renal cell carcinoma: Contending with a sea change in therapy.
|
|
Academic Article
|
DNA Methylation Signature Reveals Cell Ontogeny of Renal Cell Carcinomas.
|
|
Academic Article
|
Prognostic role of ERCC1 protein expression in upper tract urothelial carcinoma following radical nephroureterectomy with curative intent
|
|
Academic Article
|
Clinically nonmetastatic renal cell carcinoma with sarcomatoid dedifferentiation
|
|
Academic Article
|
Prediction of Pulmonary Metastasis in Renal Cell Carcinoma Patients with Indeterminate Pulmonary Nodules
|
|
Academic Article
|
Management and outcomes of patients with renal medullary carcinoma
|
|
Academic Article
|
Bladder cancer screening and future directions in urine-based markers for bladder urothelial carcinoma
|
|
Academic Article
|
Genomic DNA hypomethylation and risk of renal cell carcinoma
|
|
Academic Article
|
Renal-cell carcinoma risk estimates based on participants in the prostate, lung, colorectal, and ovarian cancer screening trial and national lung screening trial
|
|
Academic Article
|
Cytoreductive nephrectomy for metastatic renal cell carcinoma
|
|
Academic Article
|
Mucinous tubular and spindle cell carcinoma (MTSCC) of the kidney
|
|
Academic Article
|
Variability of inter-observer agreement on feasibility of partial nephrectomy before and after neoadjuvant axitinib for locally advanced renal cell carcinoma (RCC)
|
|
Academic Article
|
Prospective evaluation of plasma levels of ANGPT2, TuM2PK, and VEGF in patients with renal cell carcinoma Urological oncology
|
|
Academic Article
|
Anti-cancer strategy of transitional cell carcinoma of bladder based on induction of different types of programmed cell deaths
|
|
Academic Article
|
Management of non-clear cell renal cell carcinoma
|
|
Academic Article
|
Percentage of sarcomatoid component as a prognostic indicator for survival in renal cell carcinoma with sarcomatoid dedifferentiation
|
|
Academic Article
|
Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non-Clear Cell Renal Cell Carcinoma (ESPN)
|
|
Academic Article
|
Correlation Between Molecular Subclassifications of Clear Cell Renal Cell Carcinoma and Targeted Therapy Response
|
|
Academic Article
|
Prognosis of patients with metastatic renal cell carcinoma and pancreatic metastases
|
|
Academic Article
|
DNA methylation signature reveals cell ontogeny of renal cell carcinomas
|
|
Academic Article
|
Phase 2 trial of neoadjuvant axitinib in patients with locally advanced nonmetastatic clear cell renal cell carcinoma
|
|
Academic Article
|
Survivin is not an independent prognostic factor for patients with upper tract urothelial carcinoma
|
|
Academic Article
|
Altered Expression of the Transcription Factor Forkhead Box A1 (FOXA1) Is Associated With Poor Prognosis in Urothelial Carcinoma of the Upper Urinary Tract
|
|
Academic Article
|
Developing a clear path forward for non-clear-cell renal carcinoma
|
|
Academic Article
|
Characterization of Clinical Cases of Collecting Duct Carcinoma of the Kidney Assessed by Comprehensive Genomic Profiling
|
|
Academic Article
|
Androgen receptor expression is associated with adverse pathological features in ureteral but not in pelvicalyceal urothelial carcinomas of the upper urinary tract
|
|
Academic Article
|
The role of neoadjuvant therapy in the management of locally advanced renal cell carcinoma
|
|
Academic Article
|
Surgical Management of Local Retroperitoneal Recurrence of Renal Cell Carcinoma after Radical Nephrectomy
|
|
Academic Article
|
Prognostic role of expression of N-cadherin in patients with upper tract urothelial carcinoma
|
|
Academic Article
|
Intratumoral morphologic and molecular heterogeneity of rhabdoid renal cell carcinoma
|
|
Academic Article
|
HER2 overexpression is associated with worse outcomes in patients with upper tract urothelial carcinoma (UTUC)
|
|
Academic Article
|
Clinical and pathological complete remission in a patient with metastatic renal cell carcinoma (mrcc) treated with sunitinib
|
|
Academic Article
|
Postoperative surveillance protocols for renal cell carcinoma
|
|
Academic Article
|
The Role of Metastasectomy in Patients with Renal Cell Carcinoma with Sarcomatoid Dedifferentiation
|
|
Academic Article
|
MicroRNA profiling in clear cell renal cell carcinoma tissues potentially links tumorigenesis and recurrence with obesity
|
|
Academic Article
|
Urine cytology and commercially available urine-based markers for monitoring of bladder urothelial carcinoma
|
|
Academic Article
|
Role of targeted therapy in combination with surgery in renal cell carcinoma
|
|
Academic Article
|
Prognosticators and outcomes of patients with renal cell carcinoma and adjacent organ invasion treated with radical nephrectomy
|
|
Academic Article
|
Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma
|
|
Academic Article
|
Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma
|
|
Academic Article
|
Genomic Characterization of Renal Cell Carcinoma with Sarcomatoid Dedifferentiation Pinpoints Recurrent Genomic Alterations
|
|
Academic Article
|
Resistance to antiangiogenic therapy is associated with an immunosuppressive tumor microenvironment in metastatic Renal cell carcinoma
|
|
Academic Article
|
Sarcomatoid Renal Cell Carcinoma Has a Distinct Molecular Pathogenesis, Driver Mutation Profile, and Transcriptional Landscape.
|
|
Academic Article
|
The Adverse Survival Implications of Bland Thrombus in Renal Cell Carcinoma With Venous Tumor Thrombus.
|
|
Academic Article
|
Clinical and pathological complete remission in a patient with metastatic renal cell carcinoma (mRCC) treated with sunitinib: Is mRCC curable with targeted therapy?
|
|
Academic Article
|
Risk factors for recurrence after surgery in non-metastatic RCC with thrombus: a contemporary multicentre analysis.
|
|
Academic Article
|
Prognosis of patients with metastatic renal cell carcinoma and pancreatic metastases.
|
|
Academic Article
|
Variability of inter-observer agreement on feasibility of partial nephrectomy before and after neoadjuvant axitinib for locally advanced renal cell carcinoma (RCC): independent analysis from a phase II trial.
|
|
Academic Article
|
Characterization of Clinical Cases of Collecting Duct Carcinoma of the Kidney Assessed by Comprehensive Genomic Profiling.
|
|
Academic Article
|
Comparison of Single-docking Robotic-assisted and Traditional Laparoscopy for Retroperitoneal Lymph Node Dissection During Nephroureterectomy With Bladder Cuff Excision for Upper-tract Urothelial Carcinoma.
|
|
Academic Article
|
Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non-Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 Trial.
|
|
Academic Article
|
Genomic Characterization of Renal Cell Carcinoma with Sarcomatoid Dedifferentiation Pinpoints Recurrent Genomic Alterations.
|
|
Academic Article
|
Renal-cell carcinoma risk estimates based on participants in the prostate, lung, colorectal, and ovarian cancer screening trial and national lung screening trial.
|
|
Academic Article
|
Prognostic role of ERCC1 protein expression in upper tract urothelial carcinoma following radical nephroureterectomy with curative intent.
|
|
Academic Article
|
Positive Margins after Radical Nephrectomy with Venous Thrombectomy: Controversies and Treatment Options.
|
|
Academic Article
|
Genomic DNA Hypomethylation and Risk of Renal Cell Carcinoma: A Case-Control Study.
|
|
Academic Article
|
Prognosticators and outcomes of patients with renal cell carcinoma and adjacent organ invasion treated with radical nephrectomy.
|
|
Academic Article
|
The role of neoadjuvant therapy in the management of locally advanced renal cell carcinoma.
|
|
Academic Article
|
The Role of Metastasectomy in Patients with Renal Cell Carcinoma with Sarcomatoid Dedifferentiation: A Matched Controlled Analysis.
|
|
Academic Article
|
Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomy.
|
|
Academic Article
|
Altered Expression of the Transcription Factor Forkhead Box A1 (FOXA1) Is Associated With Poor Prognosis in Urothelial Carcinoma of the Upper Urinary Tract.
|
|
Academic Article
|
Biphasic components of sarcomatoid clear cell renal cell carcinomas are molecularly similar to each other, but distinct from, non-sarcomatoid renal carcinomas.
|
|
Academic Article
|
Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional study.
|
|
Academic Article
|
HER2 overexpression is associated with worse outcomes in patients with upper tract urothelial carcinoma (UTUC).
|
|
Academic Article
|
Cytoreductive Nephrectomy for Renal Cell Carcinoma with Venous Tumor Thrombus.
|
|
Academic Article
|
Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study.
|
|
Academic Article
|
Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative study.
|
|
Academic Article
|
Developing a Clear Path Forward for Non-Clear-Cell Renal Carcinoma.
|
|
Academic Article
|
Cytoreductive nephrectomy for metastatic renal cell carcinoma.
|
|
Academic Article
|
Study of the Kidney Tumor-Parenchymal Interface after Neoadjuvant Treatment with Axitinib for Locally Advanced Clear Cell Renal Cell Carcinoma: Matched Analysis from a Phase II Trial.
|
|
Academic Article
|
Prognostic role of expression of N-cadherin in patients with upper tract urothelial carcinoma: a multi-institutional study.
|
|
Academic Article
|
Outcomes of Patients With Metastatic Renal Cell Carcinoma and Bone Metastases in the Targeted Therapy Era.
|
|
Academic Article
|
Prognostic significance of promoter CpG island methylation of obesity-related genes in patients with nonmetastatic renal cell carcinoma.
|
|
Academic Article
|
Complications After Metastasectomy for Renal Cell Carcinoma-A Population-based Assessment.
|
|
Academic Article
|
Prognostic Value of PD-1 and PD-L1 Expression in Patients with High Grade Upper Tract Urothelial Carcinoma.
|
|
Academic Article
|
Correlation Between Molecular Subclassifications of Clear Cell Renal Cell Carcinoma and Targeted Therapy Response.
|
|
Academic Article
|
Induction and Maintenance Adjuvant Mitomycin C Topical Therapy for Upper Tract Urothelial Carcinoma: Tolerability and Intermediate Term Outcomes.
|
|
Academic Article
|
Predictive Nomogram for Recurrence following Surgery for Nonmetastatic Renal Cell Cancer with Tumor Thrombus.
|
|
Academic Article
|
Outcomes of Patients with Renal Cell Carcinoma and Sarcomatoid Dedifferentiation Treated with Nephrectomy and Systemic Therapies: Comparison between the Cytokine and Targeted Therapy Eras.
|
|
Academic Article
|
Characterization of Clinical Cases of Advanced Papillary Renal Cell Carcinoma via Comprehensive Genomic Profiling.
|
|
Academic Article
|
Local Tumor Bed Recurrence Following Partial Nephrectomy in Patients with Small Renal Masses.
|
|
Academic Article
|
Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening.
|
|
Academic Article
|
Pathologic Predictors of Survival During Lymph Node Dissection for Metastatic Renal-Cell Carcinoma: Results From a Multicenter Collaboration.
|
|
Academic Article
|
The Effects of Neoadjuvant Axitinib on Anthropometric Parameters in Patients With Locally Advanced Non-metastatic Renal Cell Carcinoma.
|
|
Academic Article
|
Frequency and Prognostic Value of PTEN Loss in Patients with Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy.
|
|
Academic Article
|
Programmed cell death ligand 1 and tumor-infiltrating lymphocyte status in patients with renal cell carcinoma and sarcomatoid dedifferentiation.
|
|
Academic Article
|
Caveolin-1 Expression in Upper Tract Urothelial Carcinoma.
|
|
Academic Article
|
The role of lymph node dissection in the management of renal cell carcinoma: a systematic review and meta-analysis.
|
|
Academic Article
|
Multi-institutional evaluation of the prognostic significance of EZH2 expression in high-grade upper tract urothelial carcinoma.
|
|
Academic Article
|
Intraoperative Conversion From Partial to Radical Nephrectomy: Incidence, Predictive Factors, and Outcomes.
|
|
Academic Article
|
Oncologic outcomes of patients with positive surgical margin after partial nephrectomy: a 25-year single institution experience.
|
|
Academic Article
|
Germline genetic variants in somatically significantly mutated genes in tumors are associated with renal cell carcinoma risk and outcome.
|
|
Academic Article
|
Predictors, utilization patterns, and overall survival of patients undergoing metastasectomy for metastatic renal cell carcinoma in the era of targeted therapy.
|
|
Academic Article
|
Conditional survival of patients with small renal masses undergoing active surveillance.
|
|
Academic Article
|
The Value of Neutrophil to Lymphocyte Ratio in Patients Undergoing Cytoreductive Nephrectomy with Thrombectomy.
|
|
Academic Article
|
Renal cell carcinoma and pathologic nodal disease: Implications for American Joint Committee on Cancer staging.
|
|
Academic Article
|
Uc.416?+?A promotes epithelial-to-mesenchymal transition through miR-153 in renal cell carcinoma.
|
|
Academic Article
|
Global and Targeted miRNA Expression Profiling in Clear Cell Renal Cell Carcinoma Tissues Potentially Links miR-155-5p and miR-210-3p to both Tumorigenesis and Recurrence.
|
|
Academic Article
|
Surgical Complications of Presurgical Systemic Therapy for Renal Cell Carcinoma: A Systematic Review.
|
|
Academic Article
|
Adjuvant therapy for advanced renal cell carcinoma.
|
|
Academic Article
|
Updated Recommendations on the Diagnosis, Management, and Clinical Trial Eligibility Criteria for Patients With Renal Medullary Carcinoma.
|
|
Academic Article
|
Prognostic significance of BAP1 expression in high-grade upper tract urothelial carcinoma: a multi-institutional study.
|
|
Academic Article
|
Systematic Review of the Role of Cytoreductive Nephrectomy in the Targeted Therapy Era and Beyond: An Individualized Approach to Metastatic Renal Cell Carcinoma.
|
|
Academic Article
|
Salvage topical therapy for upper tract urothelial carcinoma.
|
|
Academic Article
|
External validation of a predictive model of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.
|
|
Academic Article
|
Harnessing the Genomic Landscape of the Small Renal Mass to Guide Clinical Management.
|
|
Academic Article
|
Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study.
|
|
Academic Article
|
Individualised Indications for Cytoreductive Nephrectomy: Which Criteria Define the Optimal Candidates?
|
|
Academic Article
|
Epidemiological risk factors for adrenocortical carcinoma: A hospital-based case-control study.
|
|
Academic Article
|
Hybrid oncocytic/chromophobe renal tumors are molecularly distinct from oncocytoma and chromophobe renal cell carcinoma.
|
|
Academic Article
|
Temsirolimus versus Pazopanib (TemPa) in Patients with Advanced Clear-cell Renal Cell Carcinoma and Poor-risk Features: A Randomized Phase II Trial.
|
|
Academic Article
|
Evolving role of cytoreductive nephrectomy in metastatic renal cell carcinoma of variant histology.
|
|
Academic Article
|
PTRF independently predicts progression and survival in multiracial upper tract urothelial carcinoma following radical nephroureterectomy.
|
|
Academic Article
|
Molecular characterization of sarcomatoid clear cell renal cell carcinoma unveils new candidate oncogenic drivers.
|
|
Academic Article
|
EDITORIAL COMMENT.
|
|
Academic Article
|
Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma.
|
|
Academic Article
|
Optimizing patient selection for cytoreductive nephrectomy based on outcomes in the contemporary era of systemic therapy.
|
|
Academic Article
|
Macrophage HIF-1a Is an Independent Prognostic Indicator in Kidney Cancer.
|
|
Academic Article
|
Neoadjuvant Therapy for Locally Advanced Renal Cell Carcinoma.
|
|
Academic Article
|
Survival following cytoreductive nephrectomy: a comparison of existing prognostic models.
|
|
Academic Article
|
Cytoreductive Nephrectomy in Patients Presenting With Advanced Disease: Have We Finally Answered the Question?
|
|
Academic Article
|
Sarcomatoid renal cell carcinoma: biology, natural history and management.
|
|
Academic Article
|
Neoadjuvant pazopanib and molecular analysis of tissue response in renal cell carcinoma.
|
|
Academic Article
|
Outcomes of patients with metastatic renal cell carcinoma with sarcomatoid dedifferentiation to immune checkpoint inhibitors.
|
|
Academic Article
|
Prolyl Hydroxylase 3 Knockdown Accelerates VHL-Mutant Kidney Cancer Growth In Vivo.
|
|
Academic Article
|
The current role of cytoreductive nephrectomy for metastatic renal cell carcinoma.
|
|
Academic Article
|
Outcomes of Percutaneous Thermal Ablation for Biopsy-Proven T1a Renal Cell Carcinoma in Patients With Other Primary Malignancies.
|
|
Academic Article
|
Efficacy and Safety of Bevacizumab Plus Erlotinib in Patients with Renal Medullary Carcinoma.
|
|
Academic Article
|
Definitive radiotherapy for extracranial oligoprogressive metastatic renal cell carcinoma as a strategy to defer systemic therapy escalation.
|
|
Academic Article
|
Sarcomatoid features and lymph node-positive disease in chromophobe renal cell carcinoma.
|
|
Academic Article
|
MR characteristics of mucinous tubular and spindle cell carcinoma (MTSCC) of the kidney: comparison with clear cell and papillary subtypes of renal cell carcinoma.
|
|
Academic Article
|
Adjuvant therapy in patients with sarcomatoid renal cell carcinoma: post hoc analysis from Eastern Cooperative Oncology Group-American College of Radiology Imaging Network (ECOG-ACRIN) E2805.
|
|
Academic Article
|
Tumor diameter response in patients with metastatic clear cell renal cell carcinoma is associated with overall survival.
|
|
Academic Article
|
Efficacy and safety of gemcitabine plus doxorubicin in patients with renal medullary carcinoma.
|
|
Academic Article
|
Pilot study of Tremelimumab with and without cryoablation in patients with metastatic renal cell carcinoma.
|
|
Academic Article
|
Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients' Survival.
|
|
Academic Article
|
Association of High-Intensity Exercise with Renal Medullary Carcinoma in Individuals with Sickle Cell Trait: Clinical Observations and Experimental Animal Studies.
|
|
Academic Article
|
Temporal Trends in Outcomes in Patients With Adrenocortical Carcinoma: A Multidisciplinary Referral-center Experience.
|
|
Academic Article
|
Predictors of Survival in Patients Undergoing Surgery for Renal Cell Carcinoma and Inferior Vena Cava Tumor Thrombus.
|
|
Academic Article
|
Autologous Dendritic Vaccine Therapy in Metastatic Kidney Cancer: The ADAPT Trial and Beyond.
|
|
Academic Article
|
PET/MR Imaging of a Lung Metastasis Model of Clear Cell Renal Cell Carcinoma with (2S,4R)-4-[18F]Fluoroglutamine.
|
|
Academic Article
|
Epidemiology of Renal Cell Carcinoma: 2022 Update.
|
|
Academic Article
|
Outcomes of Radiofrequency Ablation for Solitary T1a Renal Cell Carcinoma: A 20-Year Tertiary Cancer Center Experience.
|
|
Academic Article
|
Cytoreductive Nephrectomy for Patients with Metastatic Sarcomatoid and/or Rhabdoid Renal Cell Carcinoma Treated with Immune Checkpoint Therapy.
|
|
Academic Article
|
Phase II trial of neoadjuvant sitravatinib plus nivolumab in patients undergoing nephrectomy for locally advanced clear cell renal cell carcinoma.
|
|
Academic Article
|
The Selection for Cytoreductive Nephrectomy (SCREEN) Score: Improving Surgical Risk Stratification by Integrating Common Radiographic Features.
|
|
Academic Article
|
Neddylation inhibition sensitises renal medullary carcinoma tumours to platinum chemotherapy.
|
|
Academic Article
|
Contemporary Patients Have Better Perioperative Outcomes Following Cytoreductive Nephrectomy: A Multi-institutional Analysis of 1272 Consecutive Patients.
|
|
Academic Article
|
Incidence and Geographical Distribution of Adrenocortical Carcinoma: Retrospective Analysis of a State Cancer Registry.
|
|
Academic Article
|
Urinary miRNAs Predict Metastasis in Patients With Clinically Localized Clear Cell Renal Cell Carcinoma Treated With Nephrectomy.
|
|
Academic Article
|
Effectiveness of Thermal Ablation for Renal Cell Carcinoma after Prior Partial Nephrectomy.
|
|
Academic Article
|
YIA24-001: Spatial Evolution of Immune Cell Dysfunction During Development of Oligometastatic Renal Cell Carcinoma: Secondary Analysis of a Prospective Trial.
|
|
Academic Article
|
Radiation Therapy for the Management of Renal Medullary Carcinoma: A Multi-Case Study.
|